http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DD-261153-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37ffeb5cafc6585168ac40b8a13b38d4
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-04
filingDate 1987-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ac9bb2b2e8641c2fa7d11539efc1b3a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0fc2d070cf45bcc00d1dbc8ae76b0b75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93b51623ea1959b7c532c2f1ccabe667
publicationDate 1988-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DD-261153-A1
titleOfInvention PROCESS FOR THE PREPARATION OF NEW 2-HETEROARYL-5-ACYLAMINO-THIAZOLENE
abstract The invention relates to a process for the preparation of novel 2-heteroaryl-5-acylaminothiazolen, which are interesting as optical brighteners, and pharmaceuticals. The aim of the invention, hitherto unknown 2-heteroaryl-5-acylaminothiazole of the formula II in which R is heteroaryl to produce in high yield and purity, was solved by heteroaryl-5-aminothiazole of formula I in geloester form with an acylating agent be implemented. Particularly suitable acylating agents are the acid anhydrides and acid chlorides, in which case an auxiliary base is added. The solvents used are the acids underlying the acylating agents, excess acylating agents themselves and aprotic solvents, preferably acetonitrile. Formula II
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006028269-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006028269-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-026654-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10005792-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014518885-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103596938-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012161879-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103596938-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9856252-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2012259335-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014128465-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9249114-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10961256-B2
priorityDate 1987-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559502
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419518040
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6342

Total number of triples: 31.